2810 Results for: "2-Amino-4-methylbenzothiazole&pageNo=59"

Supplier: Biotium

Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67 kDa (CK1); 64 kDa (CK3); 59 kDa (CK4); 58 kDa (CK5); 56 kDa (CK6); 55 kDa (CK7); 52 kDa (CK8); 56.5 kDa (CK10); 53 kDa (CK13); 50 kDa (CK14); 50 kDa (CK15); 48 kDa (CK16); 46 kDa (CK17); 45 kDa (CK18) and 40 kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas.

Supplier: Biotium

Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67 kDa (CK1); 64 kDa (CK3); 59 kDa (CK4); 58 kDa (CK5); 56 kDa (CK6); 55 kDa (CK7); 52 kDa (CK8); 56.5 kDa (CK10); 53 kDa (CK13); 50 kDa (CK14); 50 kDa (CK15); 48 kDa (CK16); 46 kDa (CK17); 45 kDa (CK18) and 40 kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas.

Supplier: Biotium

Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67 kDa (CK1); 64 kDa (CK3); 59 kDa (CK4); 58 kDa (CK5); 56 kDa (CK6); 55 kDa (CK7); 52 kDa (CK8); 56.5 kDa (CK10); 53 kDa (CK13); 50 kDa (CK14); 50 kDa (CK15); 48 kDa (CK16); 46 kDa (CK17); 45 kDa (CK18) and 40 kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas.

Supplier: Biotium

Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67 kDa (CK1); 64 kDa (CK3); 59 kDa (CK4); 58 kDa (CK5); 56 kDa (CK6); 55 kDa (CK7); 52 kDa (CK8); 56.5 kDa (CK10); 53 kDa (CK13); 50 kDa (CK14); 50 kDa (CK15); 48 kDa (CK16); 46 kDa (CK17); 45 kDa (CK18) and 40 kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas.

Supplier: Biotium

Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67 kDa (CK1); 64 kDa (CK3); 59 kDa (CK4); 58 kDa (CK5); 56 kDa (CK6); 55 kDa (CK7); 52 kDa (CK8); 56.5 kDa (CK10); 53 kDa (CK13); 50 kDa (CK14); 50 kDa (CK15); 48 kDa (CK16); 46 kDa (CK17); 45 kDa (CK18) and 40 kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas.

Supplier: Biotium

Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, with 67 kDa (CK1); 64 kDa (CK3); 59 kDa (CK4); 58 kDa (CK5); 56 kDa (CK6); 55 kDa (CK7); 52 kDa (CK8); 56.5 kDa (CK10); 53 kDa (CK13); 50 kDa (CK14); 50 kDa (CK15); 48 kDa (CK16); 46 kDa (CK17); 45 kDa (CK18) and 40 kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. KRT-PAN is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It is useful in characterizing the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and shows high sensitivity in the recognition of epithelial cells and carcinomas.

Supplier: ProSci Inc.

Mouse Interleukin 1 receptor, type II (IL1R2) is a cytokine receptor that belongs to the interleukin-1 receptor family. This protein binds interleukin alpha (IL1A), interleukin beta (IL1B), and interleukin 1 receptor, type I (IL1R1/IL1RA), and acts as a decoy receptor that inhibits the activity of its ligands. IL-1R2 structurally consisting of a ligand binding portion comprised of three Ig-like domains, a single transmembrane region, and a short cytoplasmic domain. It is expressed in a variety of cell types including B lymphocytes, neutrophils, monocytes, large granular leukocytes and endothelial cells. Mouse IL1RII shares 59% amino acid sequence homology with human IL1 RII in their extracellular domains. The pleiotropic cytokine IL1 is produced to regulate development and maintenance of the inflammatory responses, and binds to specific plasma membrane receptors on cells. Two distinct types of IL1 receptors which are able to bind IL1 specifically have been identified, designated as IL1RI (IL1RA) and IL1RII (IL1RB). IL1R1 contributes to IL-1 signalling, whereas the IL-1R2 has no signalling property and acts as a decoy for IL-1.

Supplier: ProSci Inc.

Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. This antibody detects acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins: 67 kDa (CK1); 64 kDa (CK3); 59 kDa (CK4); 58 kDa (CK5); 56 kDa (CK6); 52 kDa (CK8); 56.5 kDa (CK10); 50 kDa (CK14); 50 kDa (CK15); 48 kDa (CK16); 40 kDa (CK19). Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. It is a broad spectrum anti pan-cytokeratin antibody, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It may be useful to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has high sensitivity in the recognition of epithelial cells and carcinomas.

Supplier: ProSci Inc.

Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. This antibody is specific for the novel swine influenza Hemagglutinin and will not recognize the corresponding Hemagglutinin sequence from the seasonal H1N1 influenza (A/Brisbane/59/2007 (H1N1)).

Supplier: TCI

Geranylacetone mixture E/Z (3:2) ≥96.0% (by GC)

Supplier: MIELE

Manual cleaning can hardly guarantee a consistently high quality of glass preparation, and there are numerous other disadvantages. Only the mechanical, analytically pure preparation lays the foundation for consistency and precision in everyday laboratory work.
The profitable switch from manual glass cleaning to mechanical cleaning: Switching from manual cleaning to a laboratory washer increases efficiency and at the same time reduces the use of valuable resources such as time, water, energy, and process chemicals.

• Up to 63%* less water: The efficient, precisely calculated water requirement saves valuable resources.

• Up to 59%* less time: Professional laboratory washer achieves the desired results in less time.

• Up to 150%* higher performance: Compared to manual cleaning, the laboratory washer cleans more and more effectively laboratory glass and equipment in the same amount of time.

• Only powder dosing is possible. Neutralizing agent can be filled in through the door. If required, an external dosing pump can be connected.

• Not for pipettes (module A303) and/or vial cleaning (module A304).

• Cleaning temperature max. 70 degrees

• Not suitable for glassware contaminated with oil and grease.

Supplier: VWR Chemicals

A standard mixture, typically used for food testing, containing the following components: 100 ug/ml each of Abamectin [CAS:71751-41-2] ; Acetamiprid [CAS:135410-20-7] ; Ametryn [CAS:834-12-8] ; Amitraz [CAS:33089-61-1] ; Azoxystrobin [CAS:131860-33-8] ; Benalaxyl [CAS:71626-11-4] ; Benzoximate [CAS:29104-30-1] ; Boscalid [CAS:188425-85-6] ; Butafenacil [CAS:134605-64-4] ; Carbetamide [CAS:16118-49-3] ; Carfentrazone-ethyl [CAS:128639-02-1] ; Chlorantraniliprole [CAS:500008-45-7] ; Clofentezine [CAS:74115-24-5] ; Cymoxanil [CAS:57966-95-7] ; Cyprodinil [CAS:121552-61-2] ; Cyromazine [CAS:66215-27-8] ; Dimoxystrobin [CAS:149961-52-4] ; Dinotefuran [CAS:165252-70-0] ; Doramectin [CAS:117704-25-3] ; Eprinomectin [CAS:123997-26-2] ; Famoxadone [CAS:131807-57-3] ; Fenazaquin [CAS:120928-09-8] ; Fenhexamid [CAS:126833-17-8] ; Fenpyroximate [CAS:111812-58-9] ; Flonicamid [CAS:158062-67-0] ; Fluazinam [CAS:79622-59-6] ; Fludioxonil [CAS:131341-86-1] ; Fluoxastrobin [CAS:361377-29-9] ; Flutolanil [CAS:66332-96-5] ; Furalaxyl [CAS:57646-30-7] ; Halofenozide [CAS:112226-61-6] ; Imazalil [CAS:35554-44-0] ; Imidacloprid [CAS:138261-41-3] ; Ivermectine [CAS:70288-86-7] ; Kresoxim-methyl [CAS:143390-89-0] ; Mandipropamid [CAS:374726-62-2] ; Mepanipyrim [CAS:110235-47-7] ; Mepronil [CAS:55814-41-0] ; Metaflumizone [CAS:139968-49-3] ; Metalaxyl [CAS:57837-19-1] ; Methoxyfenozide [CAS:161050-58-4] ; Moxidectin [CAS:113507-06-5] ; Myclobutanil [CAS:88671-89-0] ; Nitenpyram [CAS:150824-47-8] ; Oxadixyl [CAS:77732-09-3] ; Picoxystrobin [CAS:117428-22-5] ; Piperonyl butoxide [CAS:51-03-6] ; Prochloraz [CAS:67747-09-5] ; Prometon [CAS:1610-18-0] ; Pymetrozine [CAS:123312-89-0] ; Pyracarbolid [CAS:24691-76-7] ; Pyrimethanil [CAS:53112-28-0] ; Pyriproxyfen [CAS:95737-68-1] ; Quinoxyfen [CAS:124495-18-7] ; Rotenone [CAS:83-79-4] ; Secbumeton [CAS:26259-45-0] ; Spiroxamine [CAS:118134-30-8] ; Tebufenozide [CAS:112410-23-8] ; Tebufenpyrad [CAS:119168-77-3] ; Terbumeton [CAS:33693-04-8] ; Triadimefon [CAS:43121-43-3] ; Trifloxystrobin [CAS:141517-21-7] ; Zoxamide [CAS:156052-68-5] in Acetonitrile

Supplier: Thermo Fisher Scientific

(E/Z)-Geranylacetone mixture E/Z 97% (Z)-isomer (nerylacetone) ∼ 45%

Supplier: TCI

(-)-Huperzine A ≥98.0% (by HPLC)

Supplier: TCI

Epothilone B ≥95.0% (by HPLC)

Supplier: Thermo Fisher Scientific

CAS No.: 62996-74-1

Supplier: Apollo Scientific

Semisynthetic derivate of Staurosporine. Inhibitor of PKC and cAMPK.

Supplier: Merck

2-Naphthylamine, Supelco®

Supplier: Merck

Valeronitrile for synthesis

Supplier: Merck

Organic Standard, Allantoin

Supplier: Thermo Fisher Scientific

Cresyl violet (acetate), pure, certified

Supplier: Merck

Organic Standard, Fluazinam

Supplier: Merck

Organic Standard, Genistin

Supplier: Apollo Scientific

Potent inhibitor of phospholipid/calcium-dependent.protein kinase.

Supplier: Merck

Organic Standard, Heptenophos

Supplier: Thermo Fisher Scientific

CAS No.: 10510-54-0

Supplier: Merck

Organic Standard, Nicotinic acid

Supplier: Merck

Organic Standard, Allantoin

Supplier: Merck

Organic Standard, Ethopabate

Supplier: Merck

Organic Standard, Metoxuron